| Expression pattern: |
UP |
| Associated gene: |
PLK4, KIF2A, MMP2, MMP9 |
| Associated microRNA: |
miR-129-5p |
| Biological function: |
CircKIF2A promotes NB cell proliferation, migration, invasion, glycolysis and tumorigenesis; circKIF2A knockdown suppresses these malignant phenotypes. |
| Molecular mechanism: |
CircKIF2A acts as a ceRNA sponge for miR-129-5p, thereby positively regulating PLK4 expression and promoting neuroblastoma progression. |
| Biological pathway or process: |
proliferation (promotes); migration (promotes); invasion (promotes); glycolysis (promotes); metastasis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Clinical Sample Validation; Transfection; MTT; Transwell Assay; Western Blot; Bioinformatics Analysis; RNA Pull-Down; Luciferase Reporter Assay; In Vivo Animal Model |
| Clinical significance: |
CircKIF2A may be a promising effective target for NB therapy. |
| Description: |
CircKIF2A is up-regulated in neuroblastoma tissues and cell lines. It promotes NB cell proliferation, migration, invasion, glycolysis and in vivo tumor growth by sponging miR-129-5p and increasing PLK4 expression. The study suggests circKIF2A as a potential therapeutic target for NB. |
| Confidence score: |
0.7936 |